MMP14 and breast carcinoma: Moreover, a recombinant human IgG specific to MMP-14 (IgG 3A2) demonstrated inhibitory effects on the growth of the primary tumor and lung metastasis in the 4T1 highly metastatic, syngeneic, orthotopic model of breast cancer (141).